The Ras small GTPase and oncoprotein that is mutationally activated in approximately 30% of all cancers. Ras and Ras-related small GTPases are involved in a myriad of cellular processes. Most studies have focused on how activated Ras utilizes two main effector signaling pathways, Raf-MEK-ERK and PI3K-AKT, in cancer initiation, development and progression. Recent studies have established a role for the non-canonical Ras effector pathway, Ral guanine nucleotide exchange factor (RalGEF) activation of-Ras-like (Ral) small GTPases, in pancreatic and other cancers. However, the mechanisms by which Ral GTPases are controlled in this pathway are still largely unknown, and how RalGEFs regulate the activation of Ral GTPases is now being explored. While there has been research focused on the GEF activity of RalGEFs, GEF- independent functions have been observed that remain poorly understood. Here, we use vulval patterning in C. elegans to study the GEF-independent functions of RalGEF (RGL-1). The canonical Ras effector in 1 deg fate induction is the LIN-45/Raf S/T kinase. However, we recently showed that the RGL-1/RalGEF-RAL-1/Ral signaling pathway functions in an antagonistic capacity relative to the Ras-Raf pathway, where Ras-RalGEF-Ral promotes 2 deg fate. Additionally, we found that RGL-1 function in the vulva is non-equivalent to that of RAL-1, suggesting RGL-1 has Ral-independent activity.
ral-1-or
rgl-1-directed RNAi enhanced the vulval hyper-induction of the activating Ras
let-60(
n1046gf) mutant, consistent with RGL-1-RAL-1 antagonism of LET-60/Ras-LIN-45/Raf. But surprisingly the three independent deletions of
rgl-1 did not enhance. However, a
rgl-1 deletion enhanced the
let-60(gf) ectopic excretory duct cell defect, showing that the
rgl-1 null mutation still antagonized Ras-Raf signaling. We hypothesize that in the vulva, RGL-1 encodes two opposing signaling activities.We used a RGL-1 GEF-dead mutant construct to rescue
rgl-1 pro-1 deg but not
pro-2 deg activity in a
let-60(gf);
rgl-1(0) background. Animals expressing the GEF-dead allele had an increase in
pro-1 deg vulva formation when compared to animals expressing wild-type RGL-1, suggesting that the GEF-independent activity of RGL-1 is necessary to promote 1 deg fate. We further confirmed that this GEF-independent function is RAL-independent. Consistent with its
pro-2 deg function, the
ral-1 promoter drives GFP expression mainly in 2 deg cells during induction. However, we observed that the
rgl-1 promoter drives GFP expression in both 1 deg and 2 deg vulva precursor cells. These results suggest that RGL-1 has dual, opposing functions in vulva cell fate patterning. A switch in RGL-1 signaling activity may contribute to robustness of vulval patterning.